Covishield - EastMojo

Serum Institute of India restarts manufacturing of COVID-19 vaccine Covishield

Serum Institute of India restarts manufacturing of Covishield

by Press Trust of India April 12, 2023

New Delhi: Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday said it has restarted manufacturing of COVID-19 vaccine Covishield amid rising numbers of cases of the virus infection. He said the company already has six million booster doses of Covovax vaccine available and adults must take the booster shot. Reacting to reports of […]

Serum Institute of India restarts manufacturing of COVID-19 vaccine Covishield

Booster dose of Covishield offers best immune response: study

by Press Trust of India January 26, 2023

One-shot chikungunya vaccine found safe in phase 3 trial: Lancet study

Coronavirus Updates

SII’s free Covishield to Centre: First lot of 80 lakh doses set for dispatch

by Press Trust of India January 14, 2023

Covishield immune responses against Covid variants higher than Covaxin: Study

Covishield immune response vs Covid variants higher than Covaxin: Study

by Press Trust of India January 8, 2023

Active Covid cases in country dip to 1,475

Serum Institute to give 2cr doses of Covishield to central govt free of cost

by Press Trust of India December 28, 2022

Obesity speeds up loss of immunity from COVID vaccines – new research

DCGI grants restricted EUA for Covid jab Corbevax for 12-18 yrs age group

by Press Trust of India February 21, 2022

Health ministry seeks 5 cr free Covishield doses from GAVI under COVAX

Reports of 50L unused Covishield doses going waste ‘misleading’: Govt

by Press Trust of India February 3, 2022

Serum Institute of India restarts manufacturing of COVID-19 vaccine Covishield

Coronavirus Updates

Covishield, Covaxin get regular market approval for use in adult population

by Press Trust of India January 27, 2022January 27, 2022

Health ministry seeks 5 cr free Covishield doses from GAVI under COVAX

Covishield vaccine as third dose effective against Omicron: Study

by Press Trust of India January 14, 2022

New study on mice paves way for developing universal flu vaccine

Coronavirus Updates

Mixing Covaxin, Covishield elicits 4 times antibody response, says study

by Press Trust of India January 4, 2022